Cargando…
Practical consensus recommendaton for adjuvant bone-modifying agents in breast cancer
Bone-modifying therapy is a primary research interest in breast cancer. Several features contribute to the importance of the bone environment in the management of breast cancer. Firstly, bone metastases represent the most common site of breast cancer metastases and secondly, the emergence of cancer...
Autores principales: | Bharatuar, A., Kar, M., Khatri, S., Goswami, V., Sarin, R., Dawood, S., Iyenger, R., Ganvir, M., Parikh, Purvish M., Aggarwal, S., Talwar, Vineet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909303/ https://www.ncbi.nlm.nih.gov/pubmed/29721471 http://dx.doi.org/10.4103/sajc.sajc_109_18 |
Ejemplares similares
-
Practical consensus recommendatons for Paget's disease in breast cancer
por: Gaurav, A., et al.
Publicado: (2018) -
Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant)
por: Singhal, M., et al.
Publicado: (2018) -
Practical consensus recommendations regarding the use of hormonal therapy in metastatic breast cancer
por: Rajappa, Senthil, et al.
Publicado: (2018) -
Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer
por: Gupta, S., et al.
Publicado: (2018) -
Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
por: Bahl, A., et al.
Publicado: (2018)